The authors demonstrated circRanBP17 to promote nasopharyngeal cancer cell proliferation and invasion by acting via mir-635 and RUNX2 and pointed out circRanBP17 as a potential target for nasopharyngeal cancer treatment. The gene discussed is RUNX2; the disease is nasopharyngeal carcinoma.